Flavia Jacobs
@flaviajacobs.bsky.social
MD
🩷 Oncologist, breast cancer
🇮🇹 Italy, Milan
🩷 Oncologist, breast cancer
🇮🇹 Italy, Milan
So many news coming for #BreastCancer at #ESMO25! 🔥
The OncoAlert Breast Cancer Faculty, led by Dr. Elisa Agostinetto🇧🇪 , has selected the OncoAlert🚨 TOP 🔟 #BreastCancer Abstracts to be presented at #ESMO25 in Berlin
September 30, 2025 at 12:47 PM
So many news coming for #BreastCancer at #ESMO25! 🔥
I highly recommend reading this super interesting paper just published in JCO:
“Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence".
📖 Full paper: ascopubs.org/doi/10.1200/...
“Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence".
📖 Full paper: ascopubs.org/doi/10.1200/...
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence
ascopubs.org
September 23, 2025 at 9:08 AM
I highly recommend reading this super interesting paper just published in JCO:
“Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence".
📖 Full paper: ascopubs.org/doi/10.1200/...
“Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence".
📖 Full paper: ascopubs.org/doi/10.1200/...